Zhou X, Yuan B, Yan Y, Nguyen K, Ruvolo V, Mu H, Mc Queen T, Shpall EJ, Do KA, Konopleva M, Andreeff M , Battula VL
The committee on Friday also voted 8 to 5 in favor of the widespread compounding of semax, which is marketed as a treatment for neurological conditions including strokes, migraines and facial nerve pain, as well as mental health disorders
Dihexa (PNB-0408) (2-4mg/kg;b.wt.;16 weeks) is promising candidates for adjunct therapies to promote limb functional recovery after surgical nerve repair, and have implications in peripheral nerve injury and limb transplantation [8]
We are grateful to Geoffrey Masuyer for assistance with crystallization and insightful discussions of the results